In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.
about
Extended-spectrum beta-lactamases: a clinical updateExtended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatbeta-Lactamases in laboratory and clinical resistanceMolecular basis of bacterial outer membrane permeability revisitedA porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement bindingCan results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonaA novel extended-spectrum TEM-type beta-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumoniaeOuter membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems.Successful interventions for gram-negative resistance to extended-spectrum beta-lactam antiobiotics.Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory.Use of an isogenic Escherichia coli panel to design tests for discrimination of beta-lactamase functional groups of Enterobacteriaceae.Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in PolandCefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.Extended-spectrum beta-lactamases: epidemiology, detection, and treatment.In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.Point mutation in the pribnow box, the molecular basis of beta-lactamase overproduction in Klebsiella oxytocaIn vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.Extended-spectrum beta-lactamases (ESbLs): characterization, epidemiology and detection.Resistance to cefoperazone-sulbactam in Klebsiella pneumoniae: evidence for enhanced resistance resulting from the coexistence of two different resistance mechanisms.An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae.Klebsiella pneumoniae Major Porins OmpK35 and OmpK36 Allow More Efficient Diffusion of β-Lactams than Their Escherichia coli Homologs OmpF and OmpC.More extended-spectrum beta-lactamasesInfections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices.The Use of Noncarbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase Infections.Involvement of a 43-kilodalton outer membrane protein in beta-lactam resistance of Shigella dysenteriae.Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals.Genetics of extended-spectrum beta-lactamases.Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.Relationship between β-lactamase production and resistance phenotype in Klebsiella pneumoniae strains.Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.The Red Menace: Emerging Issues in Antimicrobial Resistance in Gram-Negative Bacilli.
P2860
Q24534999-A458B997-3FD2-453E-AA50-02F2AAD08527Q24550671-B32813B5-919F-4E12-BF9E-581399270B02Q24669605-834E5B83-12F1-4F4E-8B75-C738459CB8C4Q29616208-17346559-978A-4067-9B52-8BB9442C8213Q30193612-99E21AAC-9763-42EC-BAED-8471945ADFB2Q33682354-E8005CEF-27CC-4132-AEB6-4D446345C96AQ33690561-BE9608D5-064C-403E-839F-AB9976E9A6B2Q33694016-2F946059-3596-4AFD-ACC6-5CC9E481FCE5Q33717167-5449E8D7-C576-4138-9295-8CD780FB7541Q33749111-DAA44757-BA98-4DC2-88AF-0FA4C3D1C3E8Q33949179-6C414179-83D4-4AF9-AB4E-B7F399E5CD7BQ33966850-85665A04-EAE1-419B-A744-63822447BD82Q33972587-C52A911A-6941-4041-8AFF-9E4DAA91C576Q33976473-53E22BCC-F9DC-4272-B0CA-343C9C603651Q33980456-D3DD8D57-E06C-4894-89C1-1C590C0FDE57Q34104447-B0E9B803-F9DA-4F6D-B9EE-2E69D9C354A1Q34244192-4D217E0E-D1E0-4F85-8F1D-93B8A2571DCAQ34445641-251B10C3-0F85-4D16-ABCF-DAD2BF015618Q35114789-FFDFBE05-7C4E-44A8-B3F0-90E9C3A64AC0Q35115498-75B0F34B-EF14-44C7-A565-4D3A1D04D343Q35122321-38D350FF-62A8-498F-BDF4-BA15070E82C3Q35134043-693B188F-D70E-4422-AD64-5662712FD593Q35254248-D4641A19-CAEC-4027-BE45-4B9E783F2C6FQ35482558-50A4CE67-D303-4B15-9447-29DDC103F078Q35552314-E00AD496-5F1B-4BDB-B21D-5F5A4AF431DDQ35760054-A0735FE4-9FDF-4E1B-8D8B-85C262AFF2C9Q35814714-1F4F806A-62D7-421F-A34F-8B58FCEC3157Q37037740-ED1BC80A-A505-4984-901E-3744504A4048Q37409385-2D6B46CC-1B78-4329-A8AA-F6B3214DEE71Q37520309-B344EFB1-C6C0-40D0-807D-5FF51524C693Q37694529-34AD1775-6C9C-4DE8-B20A-6E64377BE291Q38864569-3DBE50B4-58CE-4832-B147-99AC4D5ECB18Q39785162-639DF029-DF85-464A-A89E-A0ED90497567Q40180671-4743FD57-CEDB-46C9-B36E-947E4AD9F467Q40569199-914E10C9-3030-4FF0-B828-02F923C240B8Q41127343-2A6D0892-4A31-418F-B9D0-A6B12B2B0DD8Q41917438-7F57314F-E9F4-4BC0-B1DF-712E9670995CQ50848814-110DFC16-3D4A-4610-B17D-2E9D0B098EA2Q52695014-6EC8E407-69F8-4664-96BA-C45E88DD09AFQ54028667-451106E3-2865-4E04-B627-CD8395F78ECF
P2860
In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@en
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@nl
type
label
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@en
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@nl
prefLabel
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@en
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@nl
P2093
P356
P1476
In vivo selection of a cephamy ...... ducing a TEM-3 beta-lactamase.
@en
P2093
Philippon A
P304
P356
10.1093/INFDIS/159.5.1005
P407
P577
1989-05-01T00:00:00Z